The nation of Zimbabwe has turned down a major American healthcare agreement valued at $367m (272 million pounds) spanning five years over the United States' request for sensitive information.
The decision was revealed after a official document from December was disclosed, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".
A government spokesman later explained that the US was demanding access to genetic material for research and profit while refused to guarantee the resulting advantages from any future medical innovations.
"We must now begin the difficult and regrettable task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for continued negotiations to find a deal suitable to all parties so the country's critical HIV programme can be sustained.
Broader Context
This rejection follows a comparable situation in neighbouring Kenya, where a high court halted a similar deal with the US following legal challenges were raised about the security of Kenyans' medical information.
After resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost openness and accountability.
As per reports, Sixteen nations in Africa have to date signed these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the final treatments would be available to our population should a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the global health body and its pursuit of bilateral deals were undermining systems previously set up through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome continued dialogue with our US partners on how subsequent collaboration could be designed in a way that respects the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but urged that negotiations should continue since much of the country's Aids initiatives were funded by international support.
"In cases where specific concerns exist, including those involving information security or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," the group said.
The halted deal underscores the continuing tensions between receiving much-needed foreign assistance and safeguarding a country's data in an ever more interconnected world.